latanoprost NDC 68462-944

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-944Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0944Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-944-03	68462094403	1 BOTTLE in 1 CARTON (68462-944-03) / 2.5 mL in 1 BOTTLEMarketed from Nov 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): latanoprost
Generic name (nonproprietary): latanoprost
Active ingredients: Latanoprost — 50 ug/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: GLENMARK PHARMACEUTICALS INC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218257
Marketing start: Nov 26, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 68462-944_ff864618-ca49-4dd2-8e7f-1b14477c3a15SPL ID ff864618-ca49-4dd2-8e7f-1b14477c3a15SPL set ID 821d2ad5-a430-4fd2-8cfd-50b2118b8639RxCUI 314072UNII 6Z5B6HVF6OUPC 0368462944035

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462094403 followed by a unit qualifier and the quantity

Package 68462-0944-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 18, 2025.

Indications (excerpt from the label)

Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost ophthalmic solution is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218257

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218257
Product	Strength	Form · route	Labeler	Product NDC
Latanoprost	Latanoprost 50 ug/mL	Solution/ dropsOphthalmic	Sagent Pharmaceuticals	25021-001
latanoprost	Latanoprost 50 ug/mL	Solution/ dropsOphthalmic	Gland Pharma Limited	68083-609